Microbix Announces Extension of Share Purchase Warrants
CNW Group - Fri Mar 28, 1:03PM CDT
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES./
IIROC Trade Resumption - MBX
CNW Group - Mon Mar 17, 8:19AM CDT
Trading resumes in:
IIROC Trading Halt - MBX
CNW Group - Mon Mar 17, 8:10AM CDT
The following issues have been halted by IIROC:
Microbix Expands Customer Agreement to Approximately $17 Million Over 5 Years
CNW Group - Mon Mar 17, 8:07AM CDT
Represents Over $10 Million in Cumulative New Business
Microbix Announces Results of Vote to Elect Directors
CNW Group - Thu Mar 06, 7:00AM CST
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"
eResearch Posts Update Report on Microbix Biosystems Inc.
ACCESSWIRE - Wed Feb 26, 1:52PM CST
Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.
Microbix Closes Financing for Lumisort Prototype
CNW Group - Thu Feb 20, 7:00AM CST
Concurrently Renegotiates Agreement with Animal Genetics Firm
Microbix reports first quarter profit
CNW Group - Fri Feb 14, 7:00AM CST
Revenue Doubles on Continuing Strong Customer Demand
eResearch Posts Perspective on Microbix Biosystems Inc.
ACCESSWIRE - Mon Jan 27, 6:27AM CST
Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.
Microbix Wins VIRUSMAX® Patent Challenge In Europe
CNW Group - Thu Jan 23, 10:47AM CST
Novartis Fails to Invalidate Patent Claims
Microbix Finances Development of LumiSort® Prototype Instrument
CNW Group - Wed Jan 22, 7:00AM CST
Agreement Includes Refinancing of Existing Long-Term Debt
Microbix Sues Novartis for Infringement of its VIRUSMAX® Patent
CNW Group - Mon Jan 06, 4:00PM CST
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"
Microbix Reports Net Profit for 2013
CNW Group - Mon Dec 30, 7:05AM CST
Q4 and Full Year Revenues up due to strong customer demand
Microbix' Revenue Increases 35% in Third Quarter
CNW Group - Wed Aug 14, 7:00AM CDT
Operating Results Approach Break-Even for the Quarter
Microbix Reports Second Quarter Profit
CNW Group - Tue May 14, 7:00AM CDT
On Track for Sustainable Cash Flow and Profitability